Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Alcon Research, LLC

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Alcon Research, LLC

Regulatory records
8
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 8 FDA records to the applicant name Alcon Research, LLC. It includes 2 original PMA approvals. 6 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Jul 2, 2024 to Sep 30, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code LPO appears in 6 of the 8 linked filings. The collection spans 2 FDA product codes and 3 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P220030, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 4 linked filings have a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 20511 Lake Forest Dr., Lake Forest, CA, 92630. Recorded on P230012/S012, decision dated Sep 30, 2026.

Changes described in PMA records

P230012/S012: UNIPURE SF6 Ophthalmic Gas in the UNIFEYE Gas Delivery System

FDA recorded a 30-Day Notice decision (OK30) dated 2026-09-30 for P230012/S012, a supplement to the UNIPURE SF6 Ophthalmic Gas in the UNIFEYE Gas Delivery System, submitted by Alcon Research, LLC. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager or supplier. The recorded scope covers three manufacturing changes: an alternate supplier for UNIFEYE screen and pad printing operations, an alternate third-party supplier of ink and additive for printed components, and an alternate third-party supplier for machining and passivating the Valve Seat component.

This action concerns the manufacturing supply chain for the delivery system rather than a new approval of the gas or the complete system. The device category is gases used within the eye to place pressure on a detached retina, with ophthalmic specialty and product code LPO. No supporting documents were included in the source record, so the review basis, any testing performed and whether labeling changed remain unknown.

The OK30 code is reported as recorded; its precise administrative meaning is not defined in the source data and is not interpreted here.

FDA approval-order wording

Approval of implementing the following manufacturing changes: 1) Alternate supplier for the UNIFEYE screen and pad printing operations; 2) Alternate ink and additive third-party supplier for the UNIFEYE printed components; 3) Alternate third-party supplier to perform the machining and passivating processes for the Valve Seat component.

Sep 30, 2026 · 30-Day Notice

P220030/S012: UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System

FDA recorded an OK30 decision dated 2026-09-30 for P220030/S012, a 30-Day Notice supplement to the approved application for UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System, submitted by Alcon Research, LLC. The supplement reason is listed as a process change affecting manufacturer, sterilizer, packager or supplier. The action covers the recorded manufacturing changes only; it is not a new approval of the gas or the delivery system as a whole.

The recorded changes are three: an alternate supplier for UNIFEYE screen and pad printing operations; an alternate third-party supplier of ink and additive for printed components; and an alternate third-party supplier for machining and passivating the Valve Seat component. The device category is gases used within the eye to place pressure on a detached retina, with ophthalmic specialty and product code LPO. The source record includes no documents, so the review basis and any supplier qualification details remain unknown.

FDA approval-order wording

Approval of implementing the following manufacturing changes: 1) Alternate supplier for the UNIFEYE screen and pad printing operations; 2) Alternate ink and additive third-party supplier for the UNIFEYE printed components; 3) Alternate third-party supplier to perform the machining and passivating processes for the Valve Seat component.

Sep 30, 2026 · 30-Day Notice

P170034/S018: Hydrus Microstent

FDA’s recorded scope: approval for an alternative raw material supplier for Nitinol (NiTi) Tubing

Jun 4, 2026 · 30-Day Notice

P230012/S011: UNIPURE SF6 Ophthalmic Gas in the UNIFEYE Gas Delivery System

FDA’s recorded scope: addition of a UNIFEYE nose piece bonding fixture used on the UNIFEYE check valve subassembly during the bonding and curing processes, changing from a manual to an automated torque test fixture to verify the bonding; and updating to the torque test method used during the UNIFEYE final assembly process for torque testing of the UNIFEYE check valve and mixture stop subassemblies.

May 28, 2026 · 30-Day Notice

P220030/S011: UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System

FDA’s recorded scope: addition of a UNIFEYE nose piece bonding fixture used on the UNIFEYE check valve subassembly during the bonding and curing processes, changing from a manual to an automated torque test fixture to verify the bonding; and updating to the torque test method used during the UNIFEYE final assembly process for torque testing of the UNIFEYE check valve and mixture stop subassemblies.

May 28, 2026 · 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Source information

Source updated Nov 9, 2026. Retrieved Nov 20, 2026.